New hope for AML patients who fail venetoclax?
Disease control
Recruiting now
This pilot study tests the drug olutasidenib, with or without azacitidine, in 25 adults with a specific type of acute myeloid leukemia (IDH1-mutated) that has returned or not responded after venetoclax treatment. The goal is to see if the cancer can be brought into remission. Par…
Phase: PHASE2 • Sponsor: Timothy Pardee • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC